Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. (1st October 2016)
- Record Type:
- Journal Article
- Title:
- Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. (1st October 2016)
- Main Title:
- Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio
- Authors:
- Prokaeva, Tatiana
Spencer, Brian
Sun, Fangui
O'Hara, Richard M.
Seldin, David C.
Connors, Lawreen H.
Sanchorawala, Vaishali - Abstract:
- Abstract: Background : Serum and urine immunofixation electrophoreses (SIFE/UIFE) are used for clonal detection in plasma cell dyscrasias, while serum free light chain (sFLC) testing provides quantitation of clonal disease. Up to 20% of patients with light chain (AL) amyloidosis may present with normal FLC ratio (FLCr). Methods : We assessed the diagnostic, quantitative and prognostic potential of serum heavy light chain ratio (HLCr) in 199 untreated patients at initial evaluation. Results : An abnormal HLCr was found in 37.2%, abnormal FLCr in 81.9% and positivity by SIFE/UIFE in 94% of patients. HLCr together with SIFE/UIFE identified clonality in 94% patients; the combination with FLCr yielded 100% sensitivity. An HLCr abnormality was significantly over-represented in normal compared to abnormal FLCr group (63.9% versus 31.3%). HLCr did not predict overall survival (OS) (log rank, p = 0.09), while an abnormal FLCr was associated with decreased OS (log rank, p = 0.03). The combined use of both ratios trended toward increased OS in the abnormal HLCr/normal FLCr group (log rank, p = 0.11; Wilcoxon, p = 0.04). On multivariate analysis, HLCr was not predictive of OS, whereas an abnormal FLCr was associated with shorter OS (HR = 1.7, p = 0.04). Conclusions : The HLC assay has potential as a supplemental test to quantify monoclonal protein in patients with normal FLCr results.
- Is Part Of:
- Amyloid. Volume 23:Number 4(2016:Dec.)
- Journal:
- Amyloid
- Issue:
- Volume 23:Number 4(2016:Dec.)
- Issue Display:
- Volume 23, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 23
- Issue:
- 4
- Issue Sort Value:
- 2016-0023-0004-0000
- Page Start:
- 214
- Page End:
- 220
- Publication Date:
- 2016-10-01
- Subjects:
- AL amyloidosis -- Freelite® assay -- Hevylite® assay -- immunoglobulin heavy light chain
Amyloidosis -- Periodicals
616.3995 - Journal URLs:
- http://informahealthcare.com/loi/amy ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13506129.2016.1219715 ↗
- Languages:
- English
- ISSNs:
- 1350-6129
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0859.841173
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2494.xml